Deals

ReaMetrix raises $2.1M to develop cell lines

ReaMetrix, a company that prepares cell lines that express certain proteins over others, has brought in $2.1 million in venture capital, according to a filing with the SEC. Based in San Carlos, Calif., it is backed by Baring Private Equity Asia, Sequoia Capital India and Mobius Venture Capital.